Guhan Pharmaceutical Group Co., Ltd. (000590.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Guhan Pharmaceutical Group Co., Ltd.
—
Guhan Pharmaceutical Group Co., Ltd. is led by CEO Xue Feng, employs 1,064 people, headquartered in Hengyang, CN, publicly traded since 1996.
Guhan Pharmaceutical Group Co., Ltd. (000590.SZ) stock trades at $8.39 with a market capitalization of $2.29B. The stock is valued at a negative price-to-earnings (P/E) ratio of -46.70, reflecting a net loss over the last twelve months, price-to-book of 4.30, price-to-sales of 6.94. Over the past 52 weeks the stock has ranged between $7.47 and $12.90, and currently trades 35.0% below its 52-week high.
On profitability, Guhan Pharmaceutical Group Co., Ltd. generates a return on equity (ROE) of -8.55% (negative, reflecting a net loss), an operating margin of -9.75%, a net profit margin of -14.67%.
Official website: guhan.com
Guhan Pharmaceutical Group Co., Ltd. (000590.SZ) — frequently asked questions
What is Guhan Pharmaceutical Group Co., Ltd. (000590.SZ) stock price today?
Guhan Pharmaceutical Group Co., Ltd. (000590.SZ) is currently trading at $8.39, down 2.78% today.
What is 000590.SZ P/E ratio?
Guhan Pharmaceutical Group Co., Ltd.'s P/E ratio is -46.70. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 000590.SZ return on equity (ROE)?
Guhan Pharmaceutical Group Co., Ltd.'s return on equity (ROE) is -8.55%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Guhan Pharmaceutical Group Co., Ltd.'s market cap?
Guhan Pharmaceutical Group Co., Ltd. has a market capitalization of $2.29B.
Does 000590.SZ pay a dividend?
Guhan Pharmaceutical Group Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 000590.SZ carry?
Guhan Pharmaceutical Group Co., Ltd. has a debt-to-equity ratio of 0.13. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 000590.SZ's profit margin?
Guhan Pharmaceutical Group Co., Ltd. reports a net profit margin of -14.67% — the share of revenue left after every cost, including tax and interest.
What sector is 000590.SZ in?
Guhan Pharmaceutical Group Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 000590.SZ listed on?
Guhan Pharmaceutical Group Co., Ltd. trades on SHZ under the ticker 000590.SZ.
What is 000590.SZ's 52-week range?
Over the last year Guhan Pharmaceutical Group Co., Ltd. has traded between $7.47 and $12.90.
Related — Stocks
Popular Stocks
Screens 000590.SZ currently matches
On the figures above, Guhan Pharmaceutical Group Co., Ltd. passes the filters for 6 of our ready-made screens, among them Low Debt Stocks, Stocks Under $10, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.